Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
1.960
-0.040 (-2.00%)
Aug 4, 2025, 11:54 AM - Market open
CNTB Employees
Connect Biopharma Holdings had 62 employees as of December 31, 2024. The number of employees decreased by 19 or -23.46% compared to the previous year.
Employees
62
Change (1Y)
-19
Growth (1Y)
-23.46%
Revenue / Employee
$419,887
Profits / Employee
-$277,532
Market Cap
108.90M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62 | -19 | -23.46% |
Dec 31, 2023 | 81 | -19 | -19.00% |
Dec 31, 2022 | 100 | -8 | -7.41% |
Jan 1, 2022 | 108 | 46 | 74.19% |
Dec 31, 2020 | 62 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CNTB News
- 13 days ago - Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors - GlobeNewsWire
- 14 days ago - Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq - GlobeNewsWire
- 17 days ago - Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewsWire
- 18 days ago - Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 7 weeks ago - Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress - GlobeNewsWire
- 2 months ago - Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress - GlobeNewsWire
- 2 months ago - Connect Biopharma to Present at Two Upcoming Investor Conferences in June - GlobeNewsWire
- 2 months ago - Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference - GlobeNewsWire